Clinical Trial Update: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years [Phase 3]

View source ↗

Summary

Phase 3 trial update for a meningococcal conjugate vaccine (Group ACYW135) in children aged 2-6 years; status is active not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidemic Meningitis
• Meningococcal Infection

Drugs mentioned

• Group ACYW135 Meningococcal Conjugate Vaccine (Meningococcal conjugate vaccine ACYW135)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Epidemic Meningitis, Meningococcal Vaccines | Phase 3 | Status: ACTIVE_NOT_RECRUITING